Healthy Women – Healthy Europe
According to Article 168 of the Treaty on the Functioning of the European Union (TFEU), “everyone has the right to timely access to affordable, preventive and curative health care of good quality” and “a high level of human health protection shall be ensured in the definition and implementation of all Union policies and activities.”
Biological and social influences, notably sex and gender, are critical to health. Many factors outside of the health sector – such as socioeconomic status, environmental factors, education, culture and ethnicity – affect behaviour and resource access.
Wellbeing and economic policies are closely intertwined and mutually reinforcing. Economic growth improves people’s wellbeing, and a healthy population enhance economic growth and stability.
A comprehensive, inclusive Europe must prioritise women’s health.
In line with Articles 160 and 168 of the TEFU, the UN Sustainable Development Goals (SDGs), the European Pillar of Social Right, the Council Conclusions on the Economy of Wellbeing,and informed by the European Institute of Women’s Health EU Manifesto for Women’s Health,
I subscribe to an equitable EU that champions healthy women.
I sign-up to working with the European Institute of Women’s Health by taking concerted action to improve women’s health in Europe by reducing health inequities for all by striving to:
-
Ensure equity of opportunities for all women and men in all policies.
-
Protect health in all policies and promote wellbeing and social equity.
-
Invest in a life-course approach to health promotion and disease prevention from pre-conception to childhood through older age.
-
Integrate sex and gender in research and data.
-
Translate sex and gender differences into regulatory and health practice.
-
Evaluate and enforce Equal Treatment Directive (2006/54/EC), the Equal Pay Recommendation (2014/124/EU) and European Pact for Gender Equality.
-
Enact the Work-Life Balance Directive to address women’s underrepresentation in the paid labour market.
-
Support the Clinical Trials Regulation (536/2014) in order to combat the systematic underrepresentation of women in clinical trials.
-
Strengthen health in the Multiannual Financial Framework.
-
Evaluate the state of play for women’s health in Europe.
Signature Date